Bilirubin Blood Test Market Research Report - Global Forecast till 2027

Bilirubin Blood Test Market Research Report: Information by Test Type (Total Serum Bilirubin and others), Product Type (Consumables and Instruments), Applications (Pediatric/Infants and Adults), End User (Hospitals, Pediatric Clinics and Others) and Region (North America, Europe, Asia Pacific and Rest of the World (RoW)) - Global Forecast till 2027

ID: MRFR/LS/0249-CR | August 2019 | Region: Global | 148 pages

Please note that the assessment period of report has been updated from 2016-2027 to 2020-2027. Cordially fill the sample form for updated data.

The Global Bilirubin Blood Test Market is expected to register 5.44% CAGR and is projected to reach USD 1,853.2 Million by 2027. Bilirubin is a yellow shade pigment that is present in an individual's blood and stool.  Bilirubin is produced in the body when hemoglobin in old red platelets is broken down and result in jaundice.


The factors that influence the demand for bilirubin blood test market are the increasing prevalence of neonatal jaundice in infants and growing demand for portable/hand-held diagnostic devices. However, the testing services offered by non-laboratory personnel is hampering the growth of this market.


Market Dynamics


Increasing demand for portable/hand-held diagnostic devices is creating more opportunities for the growth of the market. For instance, there have been many technological advancements in the development of healthcare devices that are portable and energy-efficient. A portable or handheld diagnostics device allows the specialist to perform the diagnosis of the patient anywhere and anytime.


Global Bilirubin Blood Test Market Size, by Test Type, 2015 (%)  Bilirubin Blood Test Market


Source: MRFR Analysis


Segmentation


The global bilirubin blood test market has been segmented into test type, product type, application, and end user. 


Based on test type, the global market has divided into consumables and instruments. The instrument segment is further divided into analyzers and bilirubinometer. Consumables accounted for the largest market share of 56.66% in 2015.


Based on product type, the global market has been segmented into total serum bilirubin (TSB), direct/conjugated bilirubin test, and indirect/unconjugated bilirubin test. The total serum bilirubin segment held the largest market share of 47.37% in 2015.


Based on application, the global market is segmented into pediatric/infants and adults.


Based on end user, the global market has been segmented into hospitals, pediatric clinics, and home healthcare.


Key Players


The major players in the global bilirubin blood test market are Koninklijke Philips N.V. (Noord-Holland), Beckman Coulter, Inc. (US), Thermo Fisher Scientific Inc. (US), Randox Laboratories Ltd. (UK), F. Hoffmann-La Roche AG (Switzerland), Drägerwerk AG & Co. KGaA (Germany), Ginevri (Italy), Advanced Instruments (US), Reichert, Inc. (US), and Instrumentation Laboratory (US).


Some of the key strategies followed by the players operating in the global bilirubin blood test market are adopting various strategies to expand their presence in the global bilirubin blood test market and enhance their market share.


Global Bilirubin Blood Test Market Share, by Region, 2015 (%)  Bilirubin Blood Test Market


Source: MRFR Analysis


Regional Analysis


The global bilirubin blood test market, based on region, is segmented into North America, Europe, Asia Pacific, and RoW. North America accounted for the largest market share of 39.10% in 2014. The region comprises the US and Canada. The US is projected to grow with the highest CAGR of 4.93% during the forecast period. Germany holds the largest market share in the bilirubin blood test market in Europe and is expected to reach USD 158.6 million by 2027. The market in Asia-Pacific is projected to grow with the highest CAGR of 6.45%. China held the largest market share of 34.10% in the bilirubin blood test market in Asia-Pacific in 2015. The RoW is expected to have a limited market but register steady growth. The developing countries with slow advancements in the devices and less access to such advanced devices make the professionals in these countries use traditional methods and huge devices. Whereas developed countries already have access to the advanced portable bilirubin blood test devices, and developing countries, including China and India, with increasing populations, can become a potential market for bilirubin blood test devices.


Key Updates



  • In July 2016, Advanced Instruments Inc. offered a versatile portable PPM oxygen analyzer. This innovative solution was developed by Advanced Instruments Inc. to detect low oxygen contamination.



  • In November 2016, Koninklijke Philips N.V. announced the launch of its new IntelliSpace Portal 9.0 that will enhance neurological diagnosis. This is the latest version of the portal that will allow access to the clinical application from any point of the hospital network.



  • In April 2015, Bio-Rad, a global distributor of life science research and clinical diagnostic products company, extended its agreement with Beckman for the distribution of Access hepatitis C virus (HCV) assay in select geographies.


Market Segmentation


Global Bilirubin Blood Test Market, by Test Type



  • Total Serum Bilirubin (TSB)

  • Direct/Conjugated Bilirubin Test

  • Indirect/Unconjugated Bilirubin Test


Global Bilirubin Blood Test Market, by Product Type



  • Consumables

  • Instruments

    • Analyzers

      • Photometric Analyzer

      • Blood Gas Analyzers



    • Bilirubinometer

      • Bench-top

      • Hand-held






Global Bilirubin Blood Test Market, by Application



  • Paediatric/Infants

  • Adults


Global Bilirubin Blood Test Market, by End Users



  • Hospitals

  • Pediatric Clinics

  • Home Healthcare


Global Bilirubin Blood Test Market, by Imaging Type



  • North America

    • US

    • Canada





  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Rest of Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Rest of Asia-Pacific





  • Rest of the World


Available Additional Customizations



  • Additional Companies

    • Konica Minolta, Inc.

    • Natus Medical Incorporated

    • Acteon

    • Apel Health

    • Mennen Medical Ltd.

    • Lowenstein Sandler LLP

    • avihealthcare




Intended Audience



  • Pediatric clinics

  • Medical devices companies

  • Government research organizations

  • Hospitals and clinics

  • Regulatory agencies

  • Pharmaceutical companies



Frequently Asked Questions (FAQ) :


The bilirubin blood test market valuation would touch USD 1853.2 million.

The total serum bilirubin market share was 47.37%.

The applications involve pediatric/infants and adults.

The report includes hospitals, home healthcare, and pediatric clinics for discussion.

Global Bilirubin Blood Test Market – Summary


Early diagnosis of various diseases has revolutionized the modern healthcare system. It acts like a pillar on which the entire system is balancing itself. Timely detection of ailments can provide the experts with ample opportunities to cure patients. And it has been aptly supported by advancing technologies which by upgrading itself every day is bringing in new methods to simplify the diagnostic process and deliver more accurate results. Market Research Future (MRFR) in a well-studied report claims that this will drive the market towards a significantly high valuation over the forecast period (2016-2027).


The rapid changes in lifestyle have also necessitated mobility and flexibility in the entire diagnostic procedure. Portable or hand-held diagnostic devices are reaping its benefits. These chargeable devices have digital displays which give a more accurate analysis. For instance, Koninklijke Philips N.V. is manufacturing a non-invasive bilirubin measurement device, BiliChek System, that is hand-held, easy-to-use and provides precise serum bilirubin levels in the blood.  


The rising cases of neonatal jaundice are also raising eyebrows which require early and accurate detection. According to the American Family Physician (AFP), around 50% of term and 80% of preterm newborn babies show signs of jaundice during their first week after birth and is one of the most commonly recognized conditions that require immediate medical attention. This can prove beneficial for the market.


However, this diagnosis often gets performed by inefficient hands, and their lack of expertise increases the chance of error. These people are often unaware of the standard procedure which leads to the wrong diagnosis. This can be a possible market deterrent.


Industry Opportunity:


Developing countries are showing a lot of potentials in creating an expansion opportunity for several companies. According to the National Health Accounts estimates Report 2014-15, the total healthcare expenditure in India was estimated to be USD 7237.883 billion for the year 2014-15. This is indicative of the amount being spent in healthcare sector every year in countries such as India and China which also have a huge population base. Companies can inflate their business by investing in this region.


Segmentation:


By test type, the market includes serum bilirubin, direct/conjugated bilirubin test and indirect/unconjugated bilirubin test. Total serum bilirubin is currently leading the market in this particular segment. Increasing cases of liver diseases are spurring the market growth which in the future can gain a 3.77% CAGR. However, it may face steep competition from Direct/conjugated bilirubin test which is anticipating the fastest CAGR during the review period.


Based on product type, the market comprises consumables and instruments. Rising demand for portable devices has secured the top spot for consumables and ensured a 5.02% growth rate for the same during the review period. Meanwhile, the instrument segment is expecting the highest growth rate till 2023.


Application-wise, the market can be segmented into pediatric/infants and adults. Growing number of jaundice cases in infants being registered have influenced the market significantly enough to make it the highest grossing sub-segment. However, rising cases of the liver-related problem are also becoming more prevalent among adults who can ensure the fastest growth rate for this sub-segment during the assessment period.


Based on end-users, the market consists hospitals, pediatric clinics, and home healthcare. People’s reliance on hospitals have helped the sub-segment garner the maximum market share, and it is also expected to achieve an impressive CAGR of 5.70% during the review period. In the meantime, neo-natal jaundice cases are proving effective for the surge in pediatric clinics segment which is touted to grow with the highest CAGR during the forecast period.


Regional Analysis:


Cartographically, the market spans across the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).


Comprised of North and South America, the Americas are currently the frontrunner. North America is dominating the region as it has better infrastructure than most of the region and the presence of a more significant number of biotechnology companies are also boosting the market.


Europe is assuming the second spot. Rising number of jaundice cases among infants has spurred technological advancement and the need for early detection. These factors are the chief driving force for the market in the region.


The APAC is the fastest growing region. Its huge population can be considered a factor which coupled with huge investments finding their way in the healthcare segment can drive the market ahead in the foreseeable future.


The MEA contributes the lowest to the market owing to their low economic condition and weak healthcare infrastructure.


Competitive Dashboard:


The market is becoming competitive and key players are considering various strategies to expand their portfolios. Some of the key players in this market are Koninklijke Philips N.V, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Beckman Coulter, Inc., and Randox Laboratories Ltd.


Koninklijke Philips N.V and F. Hoffmann-La Roche AG have their focus set on product launches and partnerships to enhance their market presence. For instance, in November 2016, Koninklijke Philips N.V launched new IntelliSpace Portal 9.0 that will improve the neurological diagnosis. Their market rival, F. Hoffmann-La Roche AG, in June 2016, launched Cobas e 801 module that can perform up to 1200 tests per hour which will help hospitals and clinics in diagnostic testing.


On the other hand, companies such as Thermo Fisher Scientific Inc. is seeking advancement through mergers, collaboration, and acquisitions. In July 2016, the company announced its partnership with HEALTH BioMed to support the development of molecular diagnostics in China which can be considered exemplary. The same company, in September 2016, acquired the U.K.-based Alfa Aesar and also opened its new global headquarters in Waltham, Massachusetts.

1 Report Prologue

2 Market Introduction

2.1 Definition 17

2.2 Scope Of Study 18

2.3 Research Objective 18

2.4 Assumptions & Limitations 18

2.4.1 Assumptions 18

2.4.2 Limitations 18

2.5 Market Structure 19

2.6 Market Segmentation 20

2.6.1 By Test Type 20

2.6.1.1 Introduction 20

2.6.1.2 Indirect/Unconjugated Bilirubin Test 20

2.6.1.3 Direct/Conjugated Bilirubin Test 20

2.6.1.4 Total Serum Bilirubin (TSB) 21

2.6.2 By Product Type 21

2.6.2.1 Introduction 21

2.6.2.2 Consumable 21

2.6.2.3 Instruments 21

2.6.2.3.1 Analyzers 21

2.6.2.3.1.1 Photometric Analyzer 21

2.6.2.3.1.2 Blood Gas Analyzer 21

2.6.2.3.2 Bilirubinometer 22

2.6.2.3.2.1 Hand-Held 22

2.6.2.3.2.2 Bench Top 22

2.6.3 By Application 22

2.6.3.1 Introduction 22

2.6.3.2 Pediatric/Infants 22

2.6.3.3 Adults 23

2.6.4 By End User 23

2.6.4.1 Introduction 23

2.6.4.2 Hospitals 23

2.6.4.3 Pediatric Clinics 23

2.6.4.4 Home Healthcare 24

3 Research Methodolgy

3.1 Primary Research 26

3.2 Secondary Research 26

4 Market Dynamics

4.1 Introduction 27

4.2 Drivers 28

4.2.1 High Prevalence Of Neonatal Jaundice In Infants 28

4.2.2 Increasing Demand For Portable/Hand-Held Diagnostic Devices 28

4.3 Restrains 29

4.3.1 Testing Performed By Non-Laboratory Personnel 29

4.4 Opportunity 30

4.4.1 Developing Countries Can Become Potential Market For Advanced Bilirubin Blood Test Devices 30

4.5 Challenges 30

4.5.1 Risk Of Errors 30

5 Bilirubin Blood Test Market, By Test Type

5.1 Bilirubin Blood Test Market, By Test Type 31

5.2 Total Serum Bilirubin (TSB) 32

5.3 Direct/Conjugated Bilirubin Test 34

5.4 Indirect/Unconjugated Bilirubin Test 36

6 Bilirubin Blood Test Market, By Product Type

6.1 Bilirubin Blood Test Market, By Product Type 38

6.2 Consumables 39

6.3 Instruments 41

6.3.1 Analyzers 43

6.3.1.1 Photometric Analyzer 45

6.3.1.2 Blood Gas Analyzers 47

6.3.2 Bilirubinometer 49

6.3.2.1 Bench-Top 51

6.3.2.2 Hand-Held 53

7 Bilirubin Blood Test Market, By Application

7.1 Bilirubin Blood Test Market, By Application 55

7.2 Pediatric/Infants 56

7.3 Adults 58

8 Bilirubin Blood Test Market, By End User

8.1 Bilirubin Blood Test Market, By End User 60

8.2 Hospital 61

8.3 Pediatric Clinics 63

8.4 Home Healthcare 65

9 Bilirubin Blood Test Market, By Region

9.1 Bilirubin Market By Region 67

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.2 North America 67

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.2.1 US 71

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.2.2 Canada 75

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.3 Europe 78

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.3.1 Germany 81

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.3.2 UK 84

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.3.3 France 87

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.3.4 Italy 90

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.3.5 Spain 93

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.3.6 Rest Of Europe 96

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.4 Asia-Pacific 99

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.4.1 China 103

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.4.2 India 106

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.4.3 Japan 110

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.4.4 South Korea 113

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.4.5 Rest Of ASIA-PACIFIC 117

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

9.5 Rest Of The World 120

Bilirubin Blood Test Market, By Test Type

Bilirubin Blood Test Market, By Product Type

Bilirubin Blood Test Market, By Application

Bilirubin Blood Test Market, By End User

10 Company Landscape

10.1 Introduction 124

11 Company Profiles

11.1 Koninklijke Philips N.V. 128

11.1.1 Company Overview 128

11.1.2 Product/Business Segment Overview 128

11.1.3 Financials 128

11.1.4 Key Developments 129

11.2 Beckman Coulter, Inc. (Danaher) 131

11.2.1 Company Overview 131

11.2.2 Product/Business Segment Overview 131

11.2.3 Financials 132

11.2.4 Key Developments 133

11.3 Thermo Fisher Scientific Inc. 134

11.3.1 Company Overview 134

11.3.2 Product/Business Segment Overview 134

11.3.3 Financials 135

11.3.4 Key Developments 136

11.4 Randox Laboratories Ltd. 137

11.4.1 Company Overview 137

11.4.2 Product/Business Segment Overview 137

11.4.3 Financials 137

11.4.4 Key Developments 137

11.5 F. Hoffmann-La Roche AG 138

11.5.1 Company Overview 138

11.5.2 Product/Business Segment Overview 138

11.5.3 Financials 138

11.5.4 Key Developments 140

11.6 Drägerwerk AG & Co. KGaA 141

11.6.1 Overview 141

11.6.2 Product Portfolio 141

11.6.3 Financials 141

11.6.4 Key Developments 142

11.7 Ginevri 143

11.7.1 Overview 143

11.7.2 Product Portfolio 143

11.7.3 Financials 143

11.8 Advanced Instruments 144

11.8.1 Overview 144

11.8.2 Product Portfolio 144

11.8.3 Financials 144

11.8.4 Key Developments 144

11.9 Reichert, Inc. 145

11.9.1 Overview 145

11.9.2 Product Portfolio 145

11.9.3 Financials 145

11.10 Instrumentation Laboratory 146

11.10.1 Overview 146

11.10.2 Product Portfolio 146

11.10.3 Financials 146

11.10.4 Key Developments 147

12 List Of Tables

TABLE 1 GLOBAL BILIRUBIN BLOOD TEST MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 31

TABLE 2 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR TOTAL SERUM BILIRUBIN (TSB)S, BY REGION, 2020–2027 (USD MILLION) 32

TABLE 3 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 32

TABLE 4 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR TOTAL SERUM BILIRUBIN (TSB)S, BY COUNTRY, 2020–2027 (USD MILLION) 33

TABLE 5 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR TOTAL SERUM BILIRUBIN (TSB)S, BY COUNTRY, 2020–2027 (USD MILLION) 33

TABLE 6 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR DIRECT/CONJUGATED BILIRUBIN TEST, BY REGION, 2020–2027 (USD MILLION) 34

TABLE 7 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 34

TABLE 8 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR DIRECT/CONJUGATED BILIRUBIN TEST, BY COUNTRY, 2020–2027 (USD MILLION) 35

TABLE 9 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR DIRECT/CONJUGATED BILIRUBIN TEST, BY COUNTRY, 2020–2027 (USD MILLION) 35

TABLE 10 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR INDIRECT/UNCONJUGATED BILIRUBIN TEST, BY REGION, 2020–2027 (USD MILLION) 36

TABLE 11 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 36

TABLE 12 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR INDIRECT/UNCONJUGATED BILIRUBIN TEST, BY COUNTRY, 2020–2027 (USD MILLION) 37

TABLE 13 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR INDIRECT/UNCONJUGATED BILIRUBIN TEST, BY COUNTRY, 2020–2027 (USD MILLION) 37

TABLE 14 GLOBAL BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 38

TABLE 15 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR CONSUMABLES, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 16 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR CONSUMABLES, BY COUNTRY, 2020–2027 (USD MILLION) 39

TABLE 17 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR CONSUMABLES, BY COUNTRY, 2020–2027 (USD MILLION) 40

TABLE 18 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR CONSUMABLES, BY COUNTRY, 2020–2027 (USD MILLION) 40

TABLE 19 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 41

TABLE 20 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 41

TABLE 21 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 42

TABLE 22 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 42

TABLE 23 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR ANALYZERS, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 24 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 43

TABLE 25 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR ANALYZERS, BY COUNTRY, 2020–2027 (USD MILLION) 44

TABLE 26 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR ANALYZERS, BY COUNTRY, 2020–2027 (USD MILLION) 44

TABLE 27 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR PHOTOMETRIC ANALYZER, BY REGION, 2020–2027 (USD MILLION) 45

TABLE 28 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 45

TABLE 29 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR PHOTOMETRIC ANALYZER, BY COUNTRY, 2020–2027 (USD MILLION) 46

TABLE 30 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR PHOTOMETRIC ANALYZER, BY COUNTRY, 2020–2027 (USD MILLION) 46

TABLE 31 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR BLOOD GAS ANALYZERS, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 32 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 47

TABLE 33 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR BLOOD GAS ANALYZERS, BY COUNTRY, 2020–2027 (USD MILLION) 48

TABLE 34 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR BLOOD GAS ANALYZERS, BY COUNTRY, 2020–2027 (USD MILLION) 48

TABLE 35 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR BILIRUBINOMETERS, BY REGION, 2020–2027 (USD MILLION) 49

TABLE 36 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 49

TABLE 37 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR BILIRUBINOMETERS, BY COUNTRY, 2020–2027 (USD MILLION) 50

TABLE 38 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR BILIRUBINOMETERS, BY COUNTRY, 2020–2027 (USD MILLION) 50

TABLE 39 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR BENCH-TOP, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 40 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 51

TABLE 41 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR BENCH-TOP, BY COUNTRY, 2020–2027 (USD MILLION) 52

TABLE 42 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR BENCH-TOP, BY COUNTRY, 2020–2027 (USD MILLION) 52

TABLE 43 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR HAND-HELD, BY REGION, 2020–2027 (USD MILLION) 53

TABLE 44 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 53

TABLE 45 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR HAND-HELD, BY COUNTRY, 2020–2027 (USD MILLION) 54

TABLE 46 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR HAND-HELD, BY COUNTRY, 2020–2027 (USD MILLION) 54

TABLE 47 GLOBAL BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 55

TABLE 48 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC/ INFANTS, BY REGION, 2020–2027 (USD MILLION) 56

TABLE 49 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 56

TABLE 50 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC/ INFANTS, BY COUNTRY, 2020–2027 (USD MILLION) 57

TABLE 51 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC/ INFANTS, BY COUNTRY, 2020–2027 (USD MILLION) 57

TABLE 52 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR ADULTS, BY REGION, 2020–2027 (USD MILLION) 58

TABLE 53 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 58

TABLE 54 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR ADULTS, BY COUNTRY, 2020–2027 (USD MILLION) 59

TABLE 55 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR ADULTS, BY COUNTRY, 2020–2027 (USD MILLION) 59

TABLE 56 GLOBAL BILIRUBIN BLOOD TEST MARKET, BY END USER, 2020–2027 (USD MILLION) 60

TABLE 57 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION) 61

TABLE 58 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 61

TABLE 59 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 62

TABLE 60 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 62

TABLE 61 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC CLINICS, BY REGION, 2020–2027 (USD MILLION) 63

TABLE 62 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 63

TABLE 63 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 64

TABLE 64 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR PEDIATRIC CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 64

TABLE 65 GLOBAL BILIRUBIN BLOOD TEST MARKET FOR HOME HEALTHCARE, BY REGION, 2020–2027 (USD MILLION) 65

TABLE 66 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 65

TABLE 67 EUROPE: BILIRUBIN BLOOD TEST MARKET FOR HOME HEALTHCARE, BY COUNTRY, 2020–2027 (USD MILLION) 66

TABLE 68 ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET FOR HOME HEALTHCARE, BY COUNTRY, 2020–2027 (USD MILLION) 66

TABLE 69 GLOBAL BILIRUBIN BLOOD TEST MARKET, BY REGION, 2020–2027 (USD MILLION) 67

TABLE 70 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 67

TABLE 71 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 68

TABLE 72 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 68

TABLE 73 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 69

TABLE 74 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 69

TABLE 75 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 76 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2020–2027 (USD MILLION) 70

TABLE 77 NORTH AMERICA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 71

TABLE 78 US: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 71

TABLE 79 US: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 72

TABLE 80 US: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 72

TABLE 81 US: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 73

TABLE 82 US: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 73

TABLE 83 US: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2020–2027 (USD MILLION) 74

TABLE 84 US: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 74

TABLE 85 CANADA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 75

TABLE 86 CANADA: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 75

TABLE 87 CANADA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 76

TABLE 88 CANADA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 76

TABLE 89 CANADA: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 76

TABLE 90 CANADA: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2020–2027 (USD MILLION) 77

TABLE 91 CANADA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 77

TABLE 92 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 78

TABLE 93 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 78

TABLE 94 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 79

TABLE 95 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 79

TABLE 96 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 79

TABLE 97 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 80

TABLE 98 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY END EUROPEER, 2020–2027 (USD MILLION) 80

TABLE 99 EUROPE: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 81

TABLE 100 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 81

TABLE 101 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 82

TABLE 102 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 82

TABLE 103 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 82

TABLE 104 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83

TABLE 105 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY END GERMANY, 2020–2027 (USD MILLION) 83

TABLE 106 GERMANY: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 84

TABLE 107 UK: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 84

TABLE 108 UK: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 85

TABLE 109 UK: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 85

TABLE 110 UK: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 85

TABLE 111 UK: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86

TABLE 112 UK: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 86

TABLE 113 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 87

TABLE 114 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 87

TABLE 115 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 88

TABLE 116 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 88

TABLE 117 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 88

TABLE 118 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY END USERS, 2020–2027 (USD MILLION) 89

TABLE 119 FRANCE: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 89

TABLE 120 ITALY: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 90

TABLE 121 ITALY: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 90

TABLE 122 ITALY: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 91

TABLE 123 ITALY: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 91

TABLE 124 ITALY: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 92

TABLE 125 ITALY: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2020–2027 (USD MILLION) 92

TABLE 126 ITALY: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 93

TABLE 127 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 93

TABLE 128 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 94

TABLE 129 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 94

TABLE 130 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 94

TABLE 131 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 95

TABLE 132 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY END USERS, 2020–2027 (USD MILLION) 95

TABLE 133 SPAIN: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 96

TABLE 134 REST OF EUROPE : BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 97

TABLE 135 REST OF EUROPE : BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 97

TABLE 136 REST OF EUROPE : BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 97

TABLE 137 REST OF EUROPE : BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98

TABLE 138 REST OF EUROPE : BILIRUBIN BLOOD TEST MARKET, BY END USER, 2020–2027 (USD MILLION) 98

TABLE 139 REST OF EUROPE : BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 99

TABLE 140 ASIA-PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99

TABLE 141 ASIA-PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 100

TABLE 142 ASIA-PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 100

TABLE 143 ASIA-PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 101

TABLE 144 ASIA-PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 101

TABLE 145 ASIA-PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY END ASIA-PACIFICER, 2020–2027 (USD MILLION) 102

TABLE 146 ASIA-PACIFIC: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 102

TABLE 147 CHINA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 103

TABLE 148 CHINA: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 103

TABLE 149 CHINA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 104

TABLE 150 CHINA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 104

TABLE 151 CHINA: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105

TABLE 152 CHINA: BILIRUBIN BLOOD TEST MARKET, BY END CHINAER, 2020–2027 (USD MILLION) 105

TABLE 153 CHINA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 106

TABLE 154 INDIA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 106

TABLE 155 INDIA: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 107

TABLE 156 INDIA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 107

TABLE 157 INDIA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 108

TABLE 158 INDIA: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 108

TABLE 159 INDIA: BILIRUBIN BLOOD TEST MARKET, BY END USERS, 2020–2027 (USD MILLION) 109

TABLE 160 INDIA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 109

TABLE 161 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 110

TABLE 162 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 110

TABLE 163 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 111

TABLE 164 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 111

TABLE 165 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 112

TABLE 166 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY END USERS, 2020–2027 (USD MILLION) 112

TABLE 167 JAPAN: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 113

TABLE 168 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 113

TABLE 169 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 114

TABLE 170 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 114

TABLE 171 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 115

TABLE 172 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115

TABLE 173 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY END SOUTH KOREAER, 2020–2027 (USD MILLION) 116

TABLE 174 SOUTH KOREA: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 116

TABLE 175 REST OF ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 117

TABLE 176 REST OF ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 117

TABLE 177 REST OF ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 118

TABLE 178 REST OF ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 118

TABLE 179 REST OF ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119

TABLE 180 REST OF ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET, BY END REST OF ASIA-PACIFIC ER, 2020–2027 (USD MILLION) 119

TABLE 181 REST OF ASIA-PACIFIC : BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 120

TABLE 182 ROW: BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 120

TABLE 183 ROW: BILIRUBIN BLOOD TEST MARKET, BY INSTRUMENTS, 2020–2027 (USD MILLION) 121

TABLE 184 ROW: BILIRUBIN BLOOD TEST MARKET, BY ANALYZERS, 2020–2027 (USD MILLION) 121

TABLE 185 ROW: BILIRUBIN BLOOD TEST MARKET, BY BILIRUBINOMETER, 2020–2027 (USD MILLION) 122

TABLE 186 ROW: BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 122

TABLE 187 ROW: BILIRUBIN BLOOD TEST MARKET, BY END USER, 2020–2027 (USD MILLION) 123

TABLE 188 ROW: BILIRUBIN BLOOD TEST MARKET, BY TEST, 2020–2027 (USD MILLION) 123

TABLE 189 KEY DEVELOPMENTS OF MAJOR MARKET PLAYERS 125

TABLE 190 KONINKLIJKE PHILIPS N.V.: KEY DEVELOPMENTS 129

TABLE 191 BECKMAN COULTER, INC.: KEY DEVELOPMENTS 133

TABLE 192 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS 136

TABLE 193 F. HOFFMANN-LA ROCHE AG.: KEY DEVELOPMENTS 140

TABLE 194 DRÄGERWERK AG & CO. KGAA: KEY DEVELOPMENTS 142

TABLE 195 ADVANCED INSTRUMENTS: KEY DEVELOPMENTS 144

TABLE 196 INSTRUMENTATION LABORATORY: KEY DEVELOPMENTS 147

13 List Of Figures

FIGURE 1 GLOBAL BILIRUBIN BLOOD TEST MARKET SHARE, BY TEST TYPE 2020 (%) 14

FIGURE 2 GLOBAL BILIRUBIN BLOOD TEST MARKET SHARE, BY PRODUCT TYPE, 2020 (%) 15

FIGURE 3 GLOBAL BILIRUBIN BLOOD TEST MARKET SHARE, BY APPLICATIONS, 2020 (%) 15

FIGURE 4 GLOBAL BILIRUBIN MARKET SHARE, BY REGION 2020 (%) 16

FIGURE 5 GLOBAL BILIRUBIN MARKET, BY REGION, 2020-2027 (CAGR%) 16

FIGURE 6 MARKET STRUCTURE OF GLOBAL BILIRUBIN BLOOD TEST MARKET 19

FIGURE 7 RESEARCH PROCESS 25

FIGURE 8 DROC OF GLOBAL BILIRUBIN BLOOD TEST MARKET 27

FIGURE 9 GROWTH DRIVERS: IMPACT ANALYSIS 28

FIGURE 10 RESTRAINTS: IMPACT ANALYSIS 29

FIGURE 11 BILIRUBIN BLOOD TEST MARKET, BY TEST TYPE, 2020–2027 (USD MILLION) 31

FIGURE 12 BILIRUBIN BLOOD TEST MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION) 38

FIGURE 13 BILIRUBIN BLOOD TEST MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 55

FIGURE 14 BILIRUBIN BLOOD TEST MARKET, BY END USER, 2020–2027 (USD MILLION) 60

FIGURE 15 MARKET SHARE ANALYSIS BY KEY PLAYERS 2020 (%) 124

FIGURE 16 MARKET COMPETITIVE ANALYSIS BY KEY PLAYERS 2020 (%) 125

FIGURE 17 KONINKLIJKE PHILIPS N.V.: RECENT FINANCIALS 128

FIGURE 18 KONINKLIJKE PHILIPS N.V.: BUSINESS REVENUE 129

FIGURE 19 BECKMAN COULTER, INC.: RECENT FINANCIALS 132

FIGURE 20 BECKMAN COULTER, INC.: BUSINESS REVENUE 132

FIGURE 21 BECKMAN COULTER, INC.: GEOGRAPHICAL REVENUE 133

FIGURE 22 THERMO FISHER SCIENTIFIC INC.: RECENT FINANCIALS 135

FIGURE 23 THERMO FISHER SCIENTIFIC INC.: BUSINESS REVENUE 135

FIGURE 24 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHICAL REVENUE 136

FIGURE 25 F. HOFFMANN-LA ROCHE AG.: RECENT FINANCIALS 138

FIGURE 26 F. HOFFMANN-LA ROCHE AG.: BUSINESS REVENUE 139

FIGURE 27 F. HOFFMANN-LA ROCHE AG.: GEOGRAPHICAL REVENUE 139

FIGURE 28 DRÄGERWERK AG & CO. KGAA: RECENT FINANCIALS 141

FIGURE 29 DRÄGERWERK AG & CO. KGAA: GEOGRAPHICAL REVENUE 142

Global Bilirubin Blood Test Market: Competitive Landscape


The global bilirubin blood test market is currently dominated by market players such as Koninklijke Philips N.V, F. Hoffmann-La Roche AG, Beckman Coulter, Inc., and Thermo Fisher Scientific Inc. Prominent market players are engaged in several strategies such as product launches, partnerships, and acquisitions to enhance their presence in the bilirubin blood test market.


Koninklijke Philips N.V and F. Hoffmann-La Roche AG are focused on product launches and partnerships to enhance their market presence. For instance, in November 2016, Koninklijke Philips N.V launched new IntelliSpace Portal 9.0 that will enhance the neurological diagnosis. This portal allows access to clinical applications from any point of the hospital network and provides flexibility to neurologists to access the power of advanced analysis. Additionally, in June 2016, F. Hoffmann-La Roche AG launched the new Cobas e 801 module that would support hospitals and clinics in diagnostic testing with the increasing demand in the field of diagnostics. This new model for diagnostic testing aims to deliver up to 1200 tests, each hour. Moreover, in August 2015, F. Hoffmann-La Roche AG acquired GeneWEAVE BioSciences, Inc. based in Los Gatos, California, US.


Thermo Fisher Scientific Inc. is one of the major market players in the bilirubin blood test market. The company has focused on several strategies such as acquisitions, partnerships, and expansions to strengthen its market position. For instance, in July 2016, the company announced its partnership with HEALTH BioMed to support the development of molecular diagnostics in China. The partnership with BioMed will allow the company to leverage and expand its diagnostics and treatment support in China. Additionally, in September 2016, the company acquired Alfa Aesar, a company based in the UK that is focused on laboratory products and services. In the same period, the company opened its new global headquarters in Waltham, Massachusetts.